Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial

Abstract

Background Conventional anticoagulant treatment for acute deep vein thrombosis (DVT) effectively prevents thrombus extension and recurrence, but does not dissolve the clot, and many patients develop post-thrombotic syndrome (PTS). We aimed to examine whether additional treatment with catheter-directed thrombolysis (CDT) using alteplase reduced development of PTS.Methods Participants in this open-label, randomised controlled trial were recruited from 20 hospitals in the Norwegian southeastern health region. Patients aged 18-75 years with a first-time iliofemoral DVT were included within 21 days from symptom onset. Patients were randomly assigned (1:1) by picking lowest number of sealed envelopes to conventional treatment alone or additional CDT. Randomisation was stratified for involvement of the pelvic veins with blocks of six. We assessed two co-primary outcomes: frequency of PTS as assessed by Villalta score at 24 months, and iliofemoral patency after 6 months. Analyses were by intention to treat. This trial is registered at ClinicalTrials.gov, NCT00251771.Findings 209 patients were randomly assigned to treatment groups (108 control, 101 CDT). At completion of 24 months' follow-up, data for clinical status were available for 189 patients (90%; 99 control, 90 CDT). At 24 months, 37 (41·1%, 95% CI 31·5-51·4) patients allocated additional CDT presented with PTS compared with 55 (55·6%, 95% CI 45·7-65·0) in the control group (p=0·047). The difference in PTS corresponds to an absolute risk reduction of 14·4% (95% CI 0·2-27·9), and the number needed to treat was 7 (95% CI 4-502). Iliofemoral patency after 6 months was reported in 58 patients (65·9%, 95% CI 55·5-75·0) on CDT versus 45 (47·4%, 37·6-57·3) on control (p=0·012). 20 bleeding complications related to CDT included three major and five clinically relevant bleeds.Interpretation Additional CDT should be considered in patients with a high proximal DVT and low risk of bleeding.Funding South-Eastern Norway Regional Health Authority; Research Council of Norway; University of Oslo; Oslo University Hospital.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(11)61753-4

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 35 references

Research works printed but not linked: 1

  1. Villalta, 1994, Assessment of validity and reproducibility of a clinical scale for the postthrombotic syndrome, Haemostasis, 24, 157

Cited by

See all 1,000

Metadata

Authors
Enden, T., Haig, Y., Kløw, N.-E., Slagsvold, C.-E., Sandvik, L., Ghanima, W., Hafsahl, G., Holme, P. A., Holmen, L. O., Njaastad, A. M., Sandbæk, G., & Sandset, P. M.
Affiliations
  • Oslo University Hospital (NO)
  • Østfold Hospital Trust (NO)
Corresponding author
Sandset, Per Morten
Venue
The Lancet
Publisher
Elsevier BV
Published
2012-01
Volume
379
Issue
9810
Pages
31-38
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2103286082
Cited by
990
References
35
Citations by year
2026: 42 · 2025: 50 · 2024: 80 · 2023: 58 · 2022: 59 · 2021: 83 · 2020: 78 · 2019: 65 · 2018: 80 · 2017: 80 · 2016: 73 · 2015: 75 · 2014: 72 · 2013: 62 · 2012: 28
FWCI
45.29
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Funders
Universitetet i Oslo
Topics
  • Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
  • Health Sciences › Medicine › Clinical Neurology › Cerebral Venous Sinus Thrombosis
  • Health Sciences › Medicine › Surgery › Peripheral Artery Disease Management
Keywords
catheter-directed thrombolysis, alteplase, post-thrombotic syndrome, anticoagulation, bleeding complications, long-term outcomes, venous thromboembolism, Villalta score, number needed to treat, risk mitigation
MeSH terms
Acute Disease, Anticoagulants, Catheterization, Peripheral, Female, Femoral Vein, Humans, Iliac Vein, Male, Middle Aged, Thrombolytic Therapy, Treatment Outcome, Venous Thrombosis, Postthrombotic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(11)61753-4
The paper
Enden, T., Haig, Y., Kløw, N.-E., Slagsvold, C.-E., Sandvik, L., Ghanima, W., Hafsahl, G., Holme, P. A., Holmen, L. O., Njaastad, A. M., Sandbæk, G., & Sandset, P. M. (2012). Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(11)61753-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.